COSM

Cosmos Health (COSM) Price Target Increased by 50.00% to 4.59

The average one-year price target for Cosmos Health (NasdaqCM:COSM) has been revised to $4.59 / share. This is an increase of 50.00% from the prior estimate of $3.06 dated March 1, 2025.

The price target is an average of many targets provided by analysts. The latest targets range from a low of $4.54 to a high of $4.72 / share. The average price target represents an increase of 1,152.73% from the latest reported closing price of $0.37 / share.

What is the Fund Sentiment?

There are 24 funds or institutions reporting positions in Cosmos Health. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to COSM is 0.00%, an increase of 22.54%. Total shares owned by institutions increased in the last three months by 17.72% to 1,432K shares. COSM / Cosmos Health Inc. Put/Call Ratios The put/call ratio of COSM is 0.00, indicating a bullish outlook.

What are Other Shareholders Doing?

Renaissance Technologies holds 335K shares representing 0.66% ownership of the company. In its prior filing, the firm reported owning 93K shares , representing an increase of 72.26%. The firm increased its portfolio allocation in COSM by 90.09% over the last quarter.

Geode Capital Management holds 199K shares representing 0.39% ownership of the company. No change in the last quarter.

Citadel Advisors holds 123K shares representing 0.24% ownership of the company. In its prior filing, the firm reported owning 226K shares , representing a decrease of 83.11%. The firm decreased its portfolio allocation in COSM by 75.82% over the last quarter.

XTX Topco holds 100K shares representing 0.20% ownership of the company. In its prior filing, the firm reported owning 65K shares , representing an increase of 34.25%. The firm decreased its portfolio allocation in COSM by 65.47% over the last quarter.

Two Sigma Securities holds 36K shares representing 0.07% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.